一项探讨根治性膀胱切除术后腹直肌鞘导管应用的随机对照试验
这项非盲、单中心、非劣效性随机对照试验将97例开放根治性膀胱切除术患者按1:1随机分配至胸段硬膜外导管组(51例)或手术置入腹直肌鞘导管组(46例)。主要终点为术后72小时累积阿片类药物用量(口服吗啡等效剂量中位数),胸段硬膜外组为103 mg,腹直肌鞘导管组为161.75 mg,Mann-Whitney U检验证实腹直肌鞘导管在15 mg口服吗啡等效剂量阈值下非劣效于胸段硬膜外(P=0.002)。结论认为腹直肌鞘导管置入在72小时阿片类药物用量方面非劣效于胸段硬膜外,术后第3天两组疼痛控制满意度相同。
要点
- 术后72小时累积阿片类药物用量中位数:胸段硬膜外组103 mg vs 腹直肌鞘导管组161.75 mg,腹直肌鞘导管非劣效(P=0.002)。
- 术后前3天疼痛评分在麻醉后监护室停留期间早期差异 favoring 胸段硬膜外组,术后第1天后差异消失。
- 术后第3天镇痛满意度两组相似(P=0.47),其他次要结局无统计学显著差异。
核心结论
- 这项前瞻性随机试验表明,腹直肌鞘导管置入在72小时阿片类药物用量方面非劣效于胸段硬膜外。
- 术后第3天两组疼痛控制满意度相同。
研究设计与样本
- 非盲、单中心、非劣效性随机对照试验,开放根治性膀胱切除术患者按1:1随机分配至胸段硬膜外导管组或手术置入腹直肌鞘导管组。
- 共97例患者被随机分配(胸段硬膜外组51例,腹直肌鞘导管组46例)。
- 主要终点为术后前72小时累积阿片类药物用量(口服吗啡等效剂量中位数)。
- 次要结局包括视觉模拟量表疼痛评分、术后恢复指标(活动能力和恢复规律饮食时间)及并发症。
主要发现
- 口服吗啡等效剂量中位数:胸段硬膜外组103(77.5-132.5)mg vs 腹直肌鞘导管组161.75(117.5-187.5)mg。
- Mann-Whitney U检验证实腹直肌鞘导管在15 mg口服吗啡等效剂量阈值下非劣效于胸段硬膜外(P=0.002)。
- 术后前3天疼痛评分比较中,麻醉后监护室停留期间观察到早期差异 favoring 胸段硬膜外组,术后第1天后该差异消失。
- 术后第3天镇痛满意度两组相似(P=0.47)。
- 其他次要结局两组间无统计学显著差异。
关键数值与推荐
- 非劣效性阈值:15 mg口服吗啡等效剂量(P=0.002)。
- 术后第3天镇痛满意度组间比较P=0.47。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether rectus sheath catheter (RSC) insertion may be an alternative to thoracic epidural (TE). PATIENTS AND METHODS: In a non-blinded, single-centre, non-inferiority study, patients undergoing open radical cystectomy were randomized 1:1 to receive either a TE or surgically placed RSC. The primary endpoint was cumulative opiate use (median oral morphine equivalent [OME]) in the first 72 h postoperatively. Secondary outcomes included visual analogue scale pain scores, measures of postoperative recovery including mobility and time to regular diet, and complications. RESULTS: Ninety-seven patients were randomized (51 TE, 46 RSC). The median OME was 103 (77.5-132.5) mg in the TE arm and 161.75 (117.5-187.5) mg in the RSC arm. A Mann-Whitney U-test confirmed non-inferiority of RSC to TE at a threshold of 15 mg OME (P = 0.002). When comparing pain scores for the first three postoperative days, an early difference was observed that favoured the TE group during post-anaesthesia care unit stay, which was lost after postoperative day 1. Patient satisfaction with analgesia on the third postoperative day was similar in the two arms (P = 0.47). There were no statistically significant differences between arms with respect to the other secondary outcomes. CONCLUSIONS: The outcomes from this prospective randomized trial demonstrated non-inferiority of RSC insertion compared to TE with respect to 72-h opiate use. Patient satisfaction with pain control on postoperative day 3 was the same for each group.
引用
- Chedgy ECP, Tang R, Struss WJ, et al. A randomized controlled trial investigating rectus sheath catheters following radical cystectomy. BJU Int. 2023. PMID: 37259473. doi:10.1111/bju.16094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。